Interferon lambda 3 in the early phase of coronavirus disease‐19 can predict oxygen requirement

Author:

Suzuki Tetsuya12ORCID,Iwamoto Noriko12,Tsuzuki Shinya13,Kakumoto Yuko1,Suzuki Michiyo1,Ashida Shinobu1,Oshiro Yusuke4,Nemoto Takeshi4,Kanda Kohei1,Okuhama Ayako1,Yamada Gen1,Inada Makoto1,Sato Lubna1,Miyazato Yusuke1,Akiyama Yutaro1,Saito Sho12,Morioka Shinichiro12,Ujiie Mugen1,Hayakawa Kayoko1,Sugiyama Masaya56,Mizokami Masashi5,Kodama Eiichi N.7,Ohmagari Norio12

Affiliation:

1. Disease Control and Prevention Center National Center for Global Health and Medicine Tokyo Japan

2. Emerging and Re‐emerging Infectious Diseases, Graduate School of Medicine Tohoku University Sendai Japan

3. Faculty of Medicine and Health Sciences University of Antwerp Antwerp Belgium

4. Clinical Laboratory Department National Center for Global Health and Medicine Tokyo Japan

5. Genome Medical Sciences Project, Research Institute National Center for Global Health and Medicine Ichikawa Japan

6. Department of Viral Pathogenesis and Controls National Center for Global Health and Medicine Ichikawa Japan

7. Department of Infectious Disease, International Research Institute of Disaster Science Tohoku University Sendai Japan

Funder

Japan Agency for Medical Research and Development

National Center for Global Health and Medicine

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3